These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 9400344

  • 21. Are striatal dopamine D4 receptors increased in schizophrenia?
    Reynolds GP, Mason SL.
    J Neurochem; 1994 Oct; 63(4):1576-7. PubMed ID: 7931313
    [Abstract] [Full Text] [Related]

  • 22. Neonatal ventral hippocampus lesion leads to reductions in nerve growth factor inducible-B mRNA in the prefrontal cortex and increased amphetamine response in the nucleus accumbens and dorsal striatum.
    Bhardwaj SK, Beaudry G, Quirion R, Levesque D, Srivastava LK.
    Neuroscience; 2003 Oct; 122(3):669-76. PubMed ID: 14622910
    [Abstract] [Full Text] [Related]

  • 23. Human dysbindin (DTNBP1) gene expression in normal brain and in schizophrenic prefrontal cortex and midbrain.
    Weickert CS, Straub RE, McClintock BW, Matsumoto M, Hashimoto R, Hyde TM, Herman MM, Weinberger DR, Kleinman JE.
    Arch Gen Psychiatry; 2004 Jun; 61(6):544-55. PubMed ID: 15184234
    [Abstract] [Full Text] [Related]

  • 24. CHRNA7 and CHRFAM7A mRNAs: co-localized and their expression levels altered in the postmortem dorsolateral prefrontal cortex in major psychiatric disorders.
    Kunii Y, Zhang W, Xu Q, Hyde TM, McFadden W, Shin JH, Deep-Soboslay A, Ye T, Li C, Kleinman JE, Wang KH, Lipska BK.
    Am J Psychiatry; 2015 Nov 01; 172(11):1122-30. PubMed ID: 26206074
    [Abstract] [Full Text] [Related]

  • 25. Normal cellular levels of synaptophysin mRNA expression in the prefrontal cortex of subjects with schizophrenia.
    Glantz LA, Austin MC, Lewis DA.
    Biol Psychiatry; 2000 Sep 01; 48(5):389-97. PubMed ID: 10978722
    [Abstract] [Full Text] [Related]

  • 26. Antipsychotic regulation of hippocampal dopamine receptor messenger RNA expression.
    Ritter LM, Meador-Woodruff JH.
    Biol Psychiatry; 1997 Aug 01; 42(3):155-64. PubMed ID: 9232207
    [Abstract] [Full Text] [Related]

  • 27. Reduced prefrontal activity predicts exaggerated striatal dopaminergic function in schizophrenia.
    Meyer-Lindenberg A, Miletich RS, Kohn PD, Esposito G, Carson RE, Quarantelli M, Weinberger DR, Berman KF.
    Nat Neurosci; 2002 Mar 01; 5(3):267-71. PubMed ID: 11865311
    [Abstract] [Full Text] [Related]

  • 28. F15063, a potential antipsychotic with dopamine D(2)/D(3) receptor antagonist and 5-HT(1A) receptor agonist properties: influence on immediate-early gene expression in rat prefrontal cortex and striatum.
    Bruins Slot LA, Lestienne F, Grevoz-Barret C, Newman-Tancredi A, Cussac D.
    Eur J Pharmacol; 2009 Oct 12; 620(1-3):27-35. PubMed ID: 19695244
    [Abstract] [Full Text] [Related]

  • 29. Dopamine D4 receptors elevated in schizophrenia.
    Seeman P, Guan HC, Van Tol HH.
    Nature; 1993 Sep 30; 365(6445):441-5. PubMed ID: 8413587
    [Abstract] [Full Text] [Related]

  • 30. Decreased levels of D-aspartate and NMDA in the prefrontal cortex and striatum of patients with schizophrenia.
    Errico F, Napolitano F, Squillace M, Vitucci D, Blasi G, de Bartolomeis A, Bertolino A, D'Aniello A, Usiello A.
    J Psychiatr Res; 2013 Oct 30; 47(10):1432-7. PubMed ID: 23835041
    [Abstract] [Full Text] [Related]

  • 31. Heat shock protein 12A shows reduced expression in the prefrontal cortex of subjects with schizophrenia.
    Pongrac JL, Middleton FA, Peng L, Lewis DA, Levitt P, Mirnics K.
    Biol Psychiatry; 2004 Dec 15; 56(12):943-50. PubMed ID: 15601604
    [Abstract] [Full Text] [Related]

  • 32. Stimulation of adenosine A2A receptors elicits zif/268 and NMDA epsilon2 subunit mRNA expression in cortex and striatum of the "weaver" mutant mouse, a genetic model of nigrostriatal dopamine deficiency.
    Ekonomou A, Poulou PD, Matsokis N, Angelatou F.
    Neuroscience; 2004 Dec 15; 123(4):1025-36. PubMed ID: 14751293
    [Abstract] [Full Text] [Related]

  • 33. Dopaminergic abnormalities in select thalamic nuclei in schizophrenia: involvement of the intracellular signal integrating proteins calcyon and spinophilin.
    Clinton SM, Ibrahim HM, Frey KA, Davis KL, Haroutunian V, Meador-Woodruff JH.
    Am J Psychiatry; 2005 Oct 15; 162(10):1859-71. PubMed ID: 16199832
    [Abstract] [Full Text] [Related]

  • 34. Increased synaptic dopamine function in associative regions of the striatum in schizophrenia.
    Kegeles LS, Abi-Dargham A, Frankle WG, Gil R, Cooper TB, Slifstein M, Hwang DR, Huang Y, Haber SN, Laruelle M.
    Arch Gen Psychiatry; 2010 Mar 15; 67(3):231-9. PubMed ID: 20194823
    [Abstract] [Full Text] [Related]

  • 35. Alterations in synaptic proteins and their encoding mRNAs in prefrontal cortex in schizophrenia: a possible neurochemical basis for 'hypofrontality'.
    Karson CN, Mrak RE, Schluterman KO, Sturner WQ, Sheng JG, Griffin WS.
    Mol Psychiatry; 1999 Jan 15; 4(1):39-45. PubMed ID: 10089007
    [Abstract] [Full Text] [Related]

  • 36. GABA transporter-1 mRNA in the prefrontal cortex in schizophrenia: decreased expression in a subset of neurons.
    Volk D, Austin M, Pierri J, Sampson A, Lewis D.
    Am J Psychiatry; 2001 Feb 15; 158(2):256-65. PubMed ID: 11156808
    [Abstract] [Full Text] [Related]

  • 37. Evaluation of TrkB and BDNF transcripts in prefrontal cortex, hippocampus, and striatum from subjects with schizophrenia, bipolar disorder, and major depressive disorder.
    Reinhart V, Bove SE, Volfson D, Lewis DA, Kleiman RJ, Lanz TA.
    Neurobiol Dis; 2015 May 15; 77():220-7. PubMed ID: 25796564
    [Abstract] [Full Text] [Related]

  • 38. D2 and D4 dopamine receptor mRNA distribution in pyramidal neurons and GABAergic subpopulations in monkey prefrontal cortex: implications for schizophrenia treatment.
    de Almeida J, Mengod G.
    Neuroscience; 2010 Nov 10; 170(4):1133-9. PubMed ID: 20727949
    [Abstract] [Full Text] [Related]

  • 39. The striatal and extrastriatal D2/D3 receptor-binding profile of clozapine in patients with schizophrenia.
    Gründer G, Landvogt C, Vernaleken I, Buchholz HG, Ondracek J, Siessmeier T, Härtter S, Schreckenberger M, Stoeter P, Hiemke C, Rösch F, Wong DF, Bartenstein P.
    Neuropsychopharmacology; 2006 May 10; 31(5):1027-35. PubMed ID: 16237387
    [Abstract] [Full Text] [Related]

  • 40. Dopamine, the prefrontal cortex and schizophrenia.
    Knable MB, Weinberger DR.
    J Psychopharmacol; 1997 May 10; 11(2):123-31. PubMed ID: 9208376
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.